Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19

Kuo TYLin MYCoffman RLCampbell JDTraquina PLin YJLiu LTCCheng JWu YC.et al.2021-09-162021-09-162020https://scholars.lib.ntu.edu.tw/handle/123456789/583032[SDGs]SDG3Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19journal article10.1038/s41598-020-77077-z